STAT News

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

By STAT News

1 min read
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights